Cognitive-Behavioral Therapy in MS

The effectiveness of cognitive-behavioral therapy in reducing anticipatory anxiety and death anxiety in patients with multiple sclerosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220506054750N1

Enrollment

Registered

2024-01-29

Start date

2022-04-21

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group: During 8 sessions, they underwent 45-minute cognitive-behavioral therapy individually once a week. Intervention 2: Control group: No action was taken.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All MS patients referred to the MS clinic of Bo Ali Sina Hospital in Sari from May 1401 to September 1401

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: 8 sessions and once a week. Method of measurement: Anticipatory Anxiety Questionnaire; Death Anxiety Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohammad Baghbanian

Mazandaran University of Medical Sciences

mohammadbaghbanian@gmail.com+98 11 3334 3348

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026